HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Campaign targets holiday B&BW items

This article was originally published in The Rose Sheet

Executive Summary

Campaign for Safe Cosmetics encourages consumers to "tell Bath & Body Works that you don't want to give or receive toxic body products this holiday season." A major ingredient in Bath & Body Works gift baskets and holiday offerings, "fragrance" is "a mystery ingredient often made from dozens - even hundreds - of individual chemicals that don't appear on ingredient labels and that may be more naughty than nice for your health," including neurotoxins, allergens and phthalates, the Campaign asserts. But fragrance is "not the only ingredient we're checking twice," the watchdog says, noting that B&BW's Sugar & Spice 3-in-1 Body Wash contains sodium laureth sulfate - which "is often contaminated with a hidden carcinogen called 1,4-Dioxane" - and that its Glittery Gumdrop lotion is formulated with "at least two parabens." Finally, the organization advises consumers shopping for young girls to "steer clear" of B&BW's American Girl line; labeling for the American Girl Truly Me Glistening Shower and Bath Wash warns that "excessive use or prolonged exposure may cause irritation to skin and urinary tract," and the line's Shimmer roll-on fragrance also contains skin irritants, organ sensitizers and suspected carcinogens, the Campaign says. During an October investor update, B&BW CEO Diane Neal said the Limited Brands unit was optimistic about the upcoming holiday season (1"The Rose Sheet" Oct. 29, 2007, p. 6)

You may also be interested in...

Limited Brands Anticipates Winning Holiday Season, Growth Ahead

Supply-chain systems improvements and inventory efficiencies - as well as a fourth-quarter fragrance launch for the first time in the company's history - have Limited Brands' Bath & Body Works segment highly optimistic about the upcoming holiday season

Neuroscience Challenges Oncology For Top Spot In CDER’s 2019 Novel Approvals

Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.

In Case You Missed It … News On China Patents, EMA Chief, And More

We clean out your Martin Luther King Day inbox so you don't have to.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts